Magnetic Resonance Elastography of Cardiac Transplant Rejection

Status Terminated

Clinical Trial Summary

Magnetic Resonance Elastography (MRE) for cardiac transplant patients.

Clinical Trial Description

Patient will undergo MRE beginning 4-8 weeks post transplant, then with each scheduled cardiac biopsy through 7-8 months post transplant. Results of the MRE will be compared against results of the cardiac biopsy to determine if the non-invasive MRE can predict cardiac transplant rejection. ;

Study Design

Related Conditions & MeSH terms

Acute Graft Rejection

Clinical Trial Details

NCT number	NCT02266914
Study type	Interventional
Source	Ohio State University
Contact
Status	Terminated
Phase	N/A
Start date	January 27, 2014
Completion date	December 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02581436` - Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR	N/A
Recruiting	`NCT01346397` - Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation	N/A
Completed	`NCT02597543` - Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction	Phase 4
Completed	`NCT02633826` - Pre-formed Alloreactivity in Renal Transplant Recipients
Completed	`NCT01265537` - A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf	N/A
Completed	`NCT02261870` - Detection of Acute Graft Rejection in Heart Transplant Patients by Estimation of T2	N/A
Terminated	`NCT01296061` - Kidney Transplant Failure
Completed	`NCT00321906` - Comparison of Sirolimus and Azathioprine in Lung Transplantation	Phase 4